Field evaluation of anthelmintic drug sensitivity using in vitro egg hatch and larval motility assays with Necator americanus recovered from human clinical isolates.
A field-applicable assay for testing anthelmintic sensitivity is required to monitor for anthelmintic resistance. We undertook a study to evaluate the ability of three in vitro assay systems to define drug sensitivity of clinical isolates of the human hookworm parasite Necator americanus recovered from children resident in a village in Madang Province, Papua New Guinea. The assays entailed observation of drug effects on egg hatch (EHA), larval development (LDA), and motility of infective stage larvae (LMA). The egg hatch assay proved the best method for assessing the response to benzimidazole anthelmintics, while the larval motility assay was suitable for assessing the response to ivermectin. The performance of the larval development assay was unsatisfactory on account of interference caused by contaminating bacteria. A simple protocol was developed whereby stool samples were subdivided and used for immediate egg recovery, as well as for faecal culture, in order to provide eggs and infective larvae, respectively, for use in the egg hatch assay and larval motility assay systems. While the assays proved effective in quantifying drug sensitivity in larvae of the drug-susceptible hookworms examined in this study, their ability to indicate drug resistance in larval or adult hookworms remains to be determined.
Kotze
A C
AC
CSIRO Livestock Industries, Queensland Bioscience Precinct, 306 Carmody Road, St Lucia, Qld 4067, Australia. andrew.kotze@csiro.au
Coleman
G T
GT
Mai
A
A
McCarthy
J S
JS
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D004351:Drug Resistance; D005243:Feces / Q000469:parasitology; D006801:Humans; D007814:Larva; D009068:Movement; D017221:Necator americanus; D009332:Necatoriasis / Q000188:drug therapy / Q000469:parasitology*; D033661:Oocysts; D021261:Parasitic Sensitivity Tests
D000871:Anthelmintics